You searched for side effects - Page 7 of 311 - Medivizor
Navigation Menu

Side effects of targeted therapies to treat metastatic colorectal cancer

Side effects of targeted therapies to treat metastatic colorectal cancer

Posted by on Nov 18, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the negative side effects of targeted therapy to treat elderly and younger metastatic (spread to other parts of the body) colorectal cancer patients. Researchers suggested that side effects were different between these patients. Some background Colorectal cancer is one of the most common cancers worldwide....

Read More

Comparing the side effects of tyrosine kinase inhibitors for chronic myeloid leukemia patients

Posted by on Oct 5, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the incidence of pulmonary hypertension in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. This study concluded that treating CML patients with tyrosine kinase inhibitors can lead to mild pulmonary hypertension. Some background Tyrosine kinase inhibitors (TKIs) are a...

Read More

Side effects of ibrutinib and idelalisib treatment

Side effects of ibrutinib and idelalisib treatment

Posted by on Sep 22, 2017 in Leukemia | 0 comments

In a nutshell In this review, the authors look at the most common adverse events related to ibrutinib and idelalisib, B-cell inhibitors. The study concluded that both ibrutinib and idelalisib are effective at treating B-cell cancers, and the side effects are within a normal range compared to other similar treatments. Some background Ibrutinib and...

Read More

What are the side effects of inotuzumab ozogamicin treatment for patients with acute lymphoblastic leukaemia?

What are the side effects of inotuzumab ozogamicin treatment for patients with acute lymphoblastic leukaemia?

Posted by on Sep 3, 2017 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the adverse events of inotuzumab ozogamicin (Besponsa) for treatment of relapsed or refractory acute lymphoblastic leukaemia. This study concluded that inotuzumab ozogamicin leads to increased liver damage when compared to standard therapy. Some background Acute lymphoblastic leukaemia (ALL) occurs...

Read More

Comparing the side effects of treatment options for localized prostate cancer

Posted by on Jul 3, 2017 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the outcomes and side effects of radical prostatectomy, external beam radiation therapy, and active surveillance in men with localized prostate cancer. This study concluded that radical prostatectomy led to a greater decrease in sexual function and urinary continence compared to the other two treatment...

Read More

Altering drug dosage during chemotherapy can decrease toxic side effects for patients with NSCLC

Altering drug dosage during chemotherapy  can decrease toxic side effects for patients with NSCLC

Posted by on Apr 15, 2017 in Lung cancer | 0 comments

In a nutshell This trial examined whether altering the recommended dose of chemotherapy drugs during treatment was beneficial to patients. This trial concluded that altering doses of paclitaxel (Taxol) during chemotherapy could be beneficial to reduce neuropathy in patients with advanced non-small-cell lung cancer.      Some...

Read More

Minimally invasive procedure for BPH: The effect of the patient’s health on number of side effects

Minimally invasive procedure for BPH: The effect of the patient’s health on number of side effects

Posted by on Jan 2, 2017 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study examined the effect of the patient’s health and number of medical conditions on the occurrence of side effects after transurethral resection of the prostate (TURP). Researchers concluded that these did not affect the occurrence of side effects after TURP. Most complications after TURP were considered mild.   Some...

Read More